Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 26497 | $21,531,614,116 |
Sells | 80492 | $196,563,323,897 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 02 May 2024 | Sale | 11,427 | 16.94 | 193,573 | D |
03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 02 May 2024 | Sale | 1,326 | 16.94 | 22,462 | D |
03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 02 May 2024 | Sale | 3,477 | 16.94 | 58,900 | D |
03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 02 May 2024 | Sale | 3,503 | 16.94 | 59,341 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 08 Apr 2024 | Sale | 2,716 | 17.87 | 48,535 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 08 Apr 2024 | Sale | 762 | 17.87 | 13,617 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 08 Apr 2024 | Sale | 1,028 | 17.87 | 18,370 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 08 Apr 2024 | Sale | 2,568 | 17.87 | 45,890 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 08 Apr 2024 | Sale | 17,716 | 17.87 | 316,585 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 08 Apr 2024 | Sale | 8,858 | 17.87 | 158,292 | D |
27 Mar 2024 20:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 27 Mar 2024 | Sale | 5,140 | 17.9 | 92,006 | D |
27 Mar 2024 19:57 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 5,434 | 17.9 | 97,269 | D |
27 Mar 2024 19:58 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 27 Mar 2024 | Sale | 17,714 | 17.9 | 317,081 | D |
23 Aug 2023 19:31 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 21 Aug 2023 | Sale | 10,000 | 28.997 | 289,970 | D |
18 Jul 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 14 Jul 2023 | Sale | 100,000 | 30.0435 | 3,004,350 | D |
13 Jul 2023 20:27 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 12 Jul 2023 | Sale | 55,104 | 25.0517 | 1,380,449 | D |
13 Jul 2023 20:27 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 11 Jul 2023 | Sale | 16,498 | 25 | 412,450 | D |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 259,109 | 25.65 | 6,646,146 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 24,113 | 25.65 | 618,498 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 28,878 | 25.5138 | 736,788 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 2,688 | 25.5138 | 68,581 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 218,171 | 25.2723 | 5,513,683 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 20,304 | 25.2723 | 513,129 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 74,582 | 25.54 | 1,904,824 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 6,941 | 25.54 | 177,273 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 116,672 | 25.3302 | 2,955,325 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 10,858 | 25.3302 | 275,035 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 40,632 | 24.8 | 1,007,674 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 3,781 | 24.8 | 93,769 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 82,148 | 24.4604 | 2,009,373 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 7,645 | 24.4604 | 187,000 | I |
19 May 2023 18:54 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 17 May 2023 | Sale | 5,947 | 22.5 | 133,808 | D |
19 May 2023 18:48 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 17 May 2023 | Sale | 15,310 | 22.5 | 344,475 | D |
19 May 2023 18:43 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 17 May 2023 | Sale | 14,869 | 22.5 | 334,552 | D |
16 Jun 2023 16:38 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 15 Jun 2023 | Sale | 2,000 | 24.15 | 48,300 | D |
14 Jun 2023 17:14 | ACAD | ACADIA PHARMACEUTICALS INC | BREGE LAURA | Director | 12 Jun 2023 | Sale | 4,500 | 24.868 | 111,906 | D |
12 Jun 2023 20:48 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 08 Jun 2023 | Sale | 974 | 25.02 | 24,369 | D |
12 Jan 2024 12:04 | ACAX | HWH International Inc | WOLVERINE ASSET MANAGEMENT LLC | Former 10% owner | 10 Jan 2024 | Purchase | 200,165 | 10.66 | 2,133,759 | I |
13 Dec 2023 17:03 | ACAX | Alset Capital Acquisition Corp | YAKIRA CAPITAL MANAGEMENT, INC. | 10% | 17 Oct 2023 | Sale | 114 | 10.79 | 1,230 | I |
13 Dec 2023 17:03 | ACAX | Alset Capital Acquisition Corp | YAKIRA CAPITAL MANAGEMENT, INC. | 10% | 14 Sep 2023 | Sale | 4,565 | 10.77 | 49,165 | I |
13 Dec 2023 17:03 | ACAX | Alset Capital Acquisition Corp | YAKIRA CAPITAL MANAGEMENT, INC. | 10% | 11 Sep 2023 | Sale | 8,221 | 11.11 | 91,335 | I |
13 Dec 2023 17:03 | ACAX | Alset Capital Acquisition Corp | YAKIRA CAPITAL MANAGEMENT, INC. | 10% | 28 Aug 2023 | Sale | 12,000 | 10.83 | 129,960 | I |
13 Dec 2023 17:03 | ACAX | Alset Capital Acquisition Corp | YAKIRA CAPITAL MANAGEMENT, INC. | 10% | 25 Aug 2023 | Sale | 45,792 | 11.08 | 507,375 | I |
04 Dec 2023 21:30 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 30 Nov 2023 | Sale | 40,400 | 10.6 | 428,240 | I |
07 Aug 2023 18:24 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 04 Aug 2023 | Purchase | 400 | 7.4 | 2,960 | I |
07 Aug 2023 18:24 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 03 Aug 2023 | Purchase | 15,000 | 7.66 | 114,900 | I |
07 Aug 2023 18:24 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 03 Aug 2023 | Purchase | 3,871 | 7.72 | 29,884 | I |
07 Aug 2023 18:24 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 04 Aug 2023 | Purchase | 10 | 7 | 70 | D |
07 Aug 2023 18:24 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 03 Aug 2023 | Purchase | 8,000 | 7.72 | 61,760 | D |
07 Aug 2023 18:24 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 03 Aug 2023 | Purchase | 5,000 | 7.63 | 38,150 | D |
03 Aug 2023 12:34 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 02 Aug 2023 | Purchase | 7,519 | 6.9 | 51,881 | I |
03 Aug 2023 12:34 | ACAX | Alset Capital Acquisition Corp | CHAN HENG FAI AMBROSE | Chief Executive Officer, 10% | 02 Aug 2023 | Purchase | 25,000 | 6.42 | 160,500 | I |
13 Mar 2024 12:34 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 12 Mar 2024 | Sale | 252 | 9.524 | 2,400 | D |
13 Mar 2024 12:36 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 12 Mar 2024 | Sale | 222 | 9.524 | 2,114 | D |
13 Mar 2024 12:33 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 12 Mar 2024 | Sale | 662 | 9.524 | 6,305 | D |
05 Mar 2024 09:49 | ACCD | Accolade Inc | MCHUGH COLIN | Chief Accounting Officer | 04 Mar 2024 | Sale | 433 | 9.635 | 4,172 | D |
05 Mar 2024 09:47 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 04 Mar 2024 | Sale | 485 | 9.635 | 4,673 | D |
21 Feb 2024 16:30 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 20 Feb 2024 | Sale | 145 | 11.986 | 1,738 | D |
21 Feb 2024 16:24 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 20 Feb 2024 | Sale | 186 | 11.986 | 2,229 | D |
21 Feb 2024 16:26 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 20 Feb 2024 | Sale | 386 | 11.986 | 4,627 | D |
21 Feb 2024 16:17 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 20 Feb 2024 | Sale | 400 | 12.09 | 4,836 | D |
14 Feb 2024 08:57 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 13 Feb 2024 | Sale | 268 | 13.028 | 3,492 | D |
14 Feb 2024 08:51 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 13 Feb 2024 | Sale | 705 | 13.028 | 9,185 | D |
14 Feb 2024 08:53 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 13 Feb 2024 | Sale | 279 | 13.028 | 3,635 | D |
05 Feb 2024 15:05 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 02 Feb 2024 | Sale | 562 | 11.591 | 6,514 | D |
05 Feb 2024 15:01 | ACCD | Accolade Inc | MCHUGH COLIN | Chief Accounting Officer | 02 Feb 2024 | Sale | 424 | 11.591 | 4,915 | D |
22 Jan 2024 14:28 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 19 Jan 2024 | Sale | 400 | 11.99 | 4,796 | D |
18 Jan 2024 10:50 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 17 Jan 2024 | Sale | 383 | 12.862 | 4,926 | D |
18 Jan 2024 10:52 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 17 Jan 2024 | Sale | 186 | 12.862 | 2,392 | D |
18 Jan 2024 10:48 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 17 Jan 2024 | Sale | 146 | 12.862 | 1,878 | D |
12 Jan 2024 11:29 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 11 Jan 2024 | Sale | 21,530 | 15.0221 | 323,426 | D |
12 Jan 2024 11:27 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 11 Jan 2024 | Sale | 770 | 14.745 | 11,354 | D |
12 Jan 2024 11:24 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 11 Jan 2024 | Sale | 255 | 14.745 | 3,760 | D |
12 Jan 2024 11:21 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 11 Jan 2024 | Sale | 267 | 14.745 | 3,937 | D |
11 Jan 2024 18:14 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 09 Jan 2024 | Sale | 36,199 | 15.0046 | 543,152 | D |
11 Jan 2024 18:14 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 10 Jan 2024 | Sale | 67,271 | 15.034 | 1,011,352 | D |
04 Jan 2024 09:04 | ACCD | Accolade Inc | MCHUGH COLIN | Chief Accounting Officer | 03 Jan 2024 | Sale | 446 | 11.402 | 5,085 | D |
04 Jan 2024 09:05 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 03 Jan 2024 | Sale | 590 | 11.402 | 6,727 | D |
20 Dec 2023 12:55 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 19 Dec 2023 | Sale | 151 | 10.892 | 1,645 | D |
20 Dec 2023 12:57 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 19 Dec 2023 | Sale | 116 | 10.892 | 1,263 | D |
20 Dec 2023 12:51 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 19 Dec 2023 | Sale | 366 | 10.892 | 3,986 | D |
20 Dec 2023 12:49 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 19 Dec 2023 | Sale | 400 | 10.76 | 4,304 | D |
13 Dec 2023 10:49 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 12 Dec 2023 | Sale | 221 | 9.23 | 2,040 | D |
13 Dec 2023 10:52 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 12 Dec 2023 | Sale | 226 | 9.23 | 2,086 | D |
13 Dec 2023 10:53 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 12 Dec 2023 | Sale | 677 | 9.23 | 6,249 | D |
05 Dec 2023 14:36 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 04 Dec 2023 | Sale | 468 | 9.07 | 4,245 | D |
05 Dec 2023 14:34 | ACCD | Accolade Inc | MCHUGH COLIN | Chief Accounting Officer | 04 Dec 2023 | Sale | 353 | 9.07 | 3,202 | D |
20 Nov 2023 11:27 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 17 Nov 2023 | Sale | 358 | 7.942 | 2,843 | D |
20 Nov 2023 11:28 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 17 Nov 2023 | Sale | 149 | 7.942 | 1,183 | D |
20 Nov 2023 11:23 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 17 Nov 2023 | Sale | 114 | 7.942 | 905 | D |
14 Nov 2023 15:44 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 13 Nov 2023 | Sale | 223 | 6.9935 | 1,560 | D |
14 Nov 2023 15:21 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 13 Nov 2023 | Sale | 217 | 6.9935 | 1,518 | D |
14 Nov 2023 15:14 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 13 Nov 2023 | Sale | 666 | 6.9935 | 4,658 | D |
03 Nov 2023 14:00 | ACCD | Accolade Inc | MCHUGH COLIN | Chief Accounting Officer | 02 Nov 2023 | Sale | 345 | 6.882 | 2,374 | D |
03 Nov 2023 14:02 | ACCD | Accolade Inc | ESKEW RICHARD | EVP General Counsel | 02 Nov 2023 | Sale | 456 | 6.882 | 3,138 | D |
18 Oct 2023 10:54 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 17 Oct 2023 | Sale | 118 | 7.218 | 852 | D |
18 Oct 2023 10:52 | ACCD | Accolade Inc | CAVANAUGH ROBERT N | President | 17 Oct 2023 | Sale | 153 | 7.218 | 1,104 | D |
18 Oct 2023 10:31 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 17 Oct 2023 | Sale | 371 | 7.218 | 2,678 | D |
12 Oct 2023 12:06 | ACCD | Accolade Inc | SINGH RAJEEV | Chief Executive Officer | 11 Oct 2023 | Sale | 659 | 8.627 | 5,685 | D |
12 Oct 2023 12:01 | ACCD | Accolade Inc | BARNES STEPHEN H. | Chief Financial Officer | 11 Oct 2023 | Sale | 220 | 8.627 | 1,898 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)